Patent ID: 8273710
Filing Date: 2012-09-25
Classification: A23J,A23V,A61K,A61P,C07K,C12P

Abstract:
1. A method for treatment a condition mediated by dipeptidyl peptidase IV (DPP-IV) selected from the group consisting of obesity, type 2 diabetes mellitus, and autoimmune disease, comprising administering to a subject in need thereof an effective amount of a composition comprising a protein hydrolysate enriched in peptides of 3-7 amino acids, wherein at least one said peptides is selected from the group consisting of MPLW (SEQ ID NO: 6), LPQYL (SEQ ID NO: 36), LPVPQ (SEQ ID NO:37), GPFP (SEQ ID NO: 32), PLLQ (SEQ ID NO: 33), VPYPQ (SEQ ID NO: 38), VPLGTQ (SEQ ID NO: 43), LPVPQK (SEQ ID NO: 44), KVLP (SEQ ID NO: 34), and LPL.